Closed transaction

Sale of a specialist monoclonal antibodies producer

Client
Counterparty
Deal stage
Closed transaction
Service
Sell
Sector
Healthcare
Sub-sector
Biotech/Pharma Services
Market
EMEA
Contact
awimbush@ddacompany.fr

Deal details

Medix Biochemica, a global leader in critical IVD raw materials, has acquired 100 percent of the shares of Diaclone from Biotech Investissement Group. As a result of the acquisition, Medix Biochemica broadens its portfolio of critical raw materials for the in vitro diagnostics (“IVD”) industry, complements its scientific expertise and strengthens its local presence in Western Europe. Diaclone will become an important part of the Immunodiagnostic Reagents Business Unit within Medix Biochemica’s group structure, and its high-quality operations will continue in Besançon, France.

More deals in Healthcare

Sell-side advisory

NUTRIBRAIN was sold to LABORATORIOS RUBIÓ.

Where
Spain
Year
2026
Sell-side advisory

Nostos Genomics was sold to Limbus Medical Technologies (varvis®).

Where
Switzerland
Year
2025

More Healthcare

More deals in Europe

Advisory

houzy and myky join forces under Swiss Digital Home AG.

Where
Switzerland
Year
2026
Sell-side advisory

Fibreactive sold to discoverIE Group plc.

Where
United Kingdom
Year
2026
Buy-side advisory

The Vella Group acquired RGM Vehicle Body Repairs.

Where
United Kingdom
Year
2026
Sell-side advisory

Elite Vehicle Supplies received investment from Vehicle Accessories Solutions Ltd T/A Motormax.

Where
United Kingdom
Year
2026

More Europe

Membership

Gain worldwide reach with CapFive M&A professionals

The professionals of CapFive have been carefully selected on the basis of reputation, relationships, proven track record and knowledge of local markets.

Become a member

Get in touch

Find an adviser.

Contact us